PUMA BIOTECHNOLOGY, INC. Quarterly Income Tax Expense (Benefit) in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Puma Biotechnology, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q3 2024.
  • Puma Biotechnology, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $291K, a 36.6% increase year-over-year.
  • Puma Biotechnology, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.43M, a 69.4% increase year-over-year.
  • Puma Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.08M, a 138% increase from 2022.
  • Puma Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2022 was $455K, a 40.4% increase from 2021.
  • Puma Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2021 was $324K, a 56.5% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.43M $291K +$78K +36.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.35M $378K +$191K +102% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.16M $220K +$73K +49.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.08M $536K +$242K +82.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $841K $213K +$146K +218% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $695K $187K +$130K +228% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $565K $147K +$110K +297% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $455K $294K +$83K +39.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $372K $67K +$30K +81.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $342K $57K +$19K +50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $323K $37K -$1K -2.63% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $324K $211K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $37K +$37K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $38K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $38K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.